Incyte Announces that the TRuE-AD2 Pivotal Trial of Ruxolitinib Cream Met its Primary Endpoint in Patients with Atopic Dermatitis
WILMINGTON, Del.–(BUSINESS WIRE)–Jan. 28, 2020– Incyte (Nasdaq:INCY) today announced positive topline results from its randomized, vehicle-controlled, pivotal Phase 3 TRuE-AD2 study evaluating the safety and efficacy of ruxolitinib cream in adolescent and…
Rise in serious harm to children caused by powerful painkillers, says study
The proportion of high-strength painkiller poisonings among children which result in emergency hospital admissions has increased, according to research published in the peer-reviewed journal Clinical Toxicology. A study involving more…
Regional trends in overdose deaths reveal multiple opioid epidemics, according to new study
The United States is suffering from several different simultaneous opioid epidemics, rather than just a single crisis, according to an academic study of deaths caused by drug overdoses. David Peters,…
Gay, bisexual men increasingly agree: HIV ‘undetectable equals untransmittable’
Extensive evidence from HIV prevention research studies has firmly established that “Undetectable Equals Untransmittable,” or U=U. This means that people living with HIV who achieve and maintain an undetectable viral…
Study highlights ‘worrying’ increase in misuse of non-opioid medications
A major new analysis of the non-opioid medications, gabapentin and baclofen, shows “worrying” increases in related suicide attempts and hospital admissions in US adults since 2013—coinciding with a decrease in…
Cannabis reduces headache and migraine pain by nearly half
Inhaled cannabis reduces self-reported headache severity by 47.3% and migraine severity by 49.6%, according to a recent study led by Carrie Cuttler, a Washington State University assistant professor of psychology.…
Fighting opioids with an unlikely supplemental painkiller: Anti-itch medicine
Pain is a mosaic. From a distance, it looks like one big “ouch.” But if you step closer, many types of pain—like tiles of different shades—emerge. A headache doesn’t feel…
Optimizing the pharmaceutical industry
Research published in the International Journal of Simulation and Process Modelling shows how integrated simulations can be used to optimize a pharmaceutical production line in a way that conventional mathematical…
Regular use of prescription drugs for pain and sleep increases frailty risk by 95 percent
Researchers from the Oregon Research Institute (ORI) and Florida Atlantic University (FAU) are the first to demonstrate statistically significant links between self-reported regular use of prescription drugs for pain and/or…
MENACTRIMS guidelines for multiple sclerosis updated
(HealthDay)—In a revised 2019 guideline, published in the January 2020 issue of Multiple Sclerosis and Related Disorders, updated recommendations from the Middle East North Africa Committee for Treatment and Research…